Review demonstrates enhanced anti-tumor efficacy and reduced toxicity via targeted cis-delivery cytokine strategies, suggesting improved safety profiles in cancer immunotherapy.
-targeting approaches represent a promising strategy in the field, enabling efficient immunotherapies with improved tolerability and enhanced anti-tumor responses.
No takes yet. Share an insight, caveat, or question.
Pousse et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: